Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1/2 Study of UC-MSC Treatment for Evaluation the Efficacy and Safety in Patients With Primary Biliary Cirrhosis

NCT01662973 is registered in ClinicalTrials.gov with Beijing 302 Hospital as lead sponsor.

NCT NCT01662973
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01662973 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1/2 Study of UC-MSC Treatment for Evaluation the Efficacy and Safety in Patients With Primary Biliary Cirrhosis
Lead sponsor
Beijing 302 Hospital
Phase
Phase 1/2
Overall status
Unknown status
Start date
October 31, 2011
Completion date
October 31, 2013
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary biliary cirrhosis